Intracameral Injection of Methotrexate for Treatment of Epithelial Ingrowth
Farhad Salari1, Ghasem Fakhraie1, Fahimeh Asadi Amoli1
1Department of Cornea, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Purpose:
To report a case of intracameral injection of methotrexate (MTX) to treat the epithelial ingrowth that occurred following glaucoma surgery.
Methods:
A case report of a 40-year-old male with epithelial ingrowth after implantation of Ahmed glaucoma valve.
Results:
The patient was treated with 11 doses of weekly intracameral MTX (400 mg/0.1 ml). Clinical evidence of recurrence was not observed after 11 months of follow-up.
Discussion:
Intracameral MTX can be used as an alternative for the treatment of epithelial ingrowth.
More Related Videos
06:19Author Spotlight: A Novel Protocol for Intracameral Injections to Enhance Precision in Rodent Ophthalmology
Published on: May 31, 2024
06:46Ortho- and Ectopic Zebrafish Xeno-Engraftment of Ocular Melanoma to Recapitulate Primary Tumor and Experimental Metastasis Development
Published on: September 4, 2021
